48 results on '"Agnifili, Mauro"'
Search Results
2. Role of Invasive and Provocative Tests
3. In-Hospital Outcomes and Predictors of Paravalvular Leak and Deep Implantation With the Evolut R 34-mm Device: A Comparison With Smaller Evolut R Sizes
4. Morphological Changes of Anomalous Coronary Arteries From the Aorta During the Cardiac Cycle Assessed by IVUS in Resting Conditions
5. Abstract 11835: Different Dynamic Luminal Compression of Intramural Segment During Cardiac Cycle in Anomalous Aortic Origin of Coronary Arteries Revealed by Ivus Gated Sequences
6. Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement
7. Impact of balloon post‐dilation on valve durability and long‐term clinical outcomes after self‐expanding transcatheter aortic valve implantation
8. Current and Next Generation of Transcatheter Valves
9. Techniques and Devices
10. Coronary Artery anomalies in PatienTs Undergoing transcatheter aortic valve REplacement. The CAPTURE registry
11. Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison
12. Impact of balloon post‐dilation on valve durability and long‐term clinical outcomes after self‐expanding transcatheter aortic valve implantation.
13. Impact of Nodular Calcifications in the Aortic Annulus and Left Ventricular Outflow Tract on TAVI Outcome with New-Generation Devices
14. Prosthesis-patient mismatch following transcatheter aortic valve replacement for degenerated transcatheter aortic valves: the TRANSIT-PPM international project
15. Myocardial infarction with non‐obstructive disease and anomalous coronary origin: look for the common in the uncommon
16. Prosthesis-patient mismatch following transcatheter aortic valve replacement for degenerated transcatheter aortic valves:the TRANSIT-PPM international project
17. Prosthesis-patient mismatch following transcatheter aortic valve replacement for degenerated transcatheter aortic valves: the TRANSIT-PPM international project
18. Prosthesis-patient mismatch following transcatheter aortic valve replacement for degenerated transcatheter aortic valves: the TRANSIT-PPM international project
19. Selection of Medications to Prevent Stroke Among Individuals With Atrial Fibrillation: Update on Prevention of Stroke in Patients with AF
20. Improved transfemoral accessibility and positioning of the Portico transcatheter heart valve with the new FlexNav delivery system
21. Transcatheter Aortic Valve Replacement for Degenerated Transcatheter Aortic Valves: The TRANSIT International Project
22. Transcatheter Aortic Valve Replacement for Degenerated Transcatheter Aortic Valves:The TRANSIT International Project
23. Transcatheter Aortic Valve Replacement for Degenerated Transcatheter Aortic Valves: The TRANSIT International Project
24. Role of imaging in interventions on structural heart disease
25. The new era of oral anticoagulation: the ‘finger pointing to the moon is not the moon’ Reply to: Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next? By Job Harenberg, Gregory Y.H. Lip
26. One‐year safety and efficacy profile of transcatheter aortic valve‐in‐valve implantation with the portico system
27. Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut‐R , Portico, and Acurate‐NEO
28. Transcatheter aortic valve implantation with the Portico and Evolut R bioprostheses in patients with elliptic aortic annulus
29. One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system.
30. Transfemoral aortic valve implantation with new-generation devices: The repositionable Lotus vs. The balloon-expandable Edwards Sapien 3 valve
31. Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut‐R, Portico, and Acurate‐NEO.
32. TCTAP C-200 Chronic Left Main and Left Anterior Descending Dissection in a Young Woman: Optical Coherence Tomography Role to Indicate Optimal Treatment
33. ONE-YEAR CLINICAL OUTCOMES ACCORDING TO ANTITHROMBOTIC REGIMEN AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION
34. The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation
35. Persistence of Severe Pulmonary Hypertension After Transcatheter Aortic Valve Replacement
36. Transcatheter aortic valve replacement—state of the art and a glimpse to the future: ‘the Tailored Approach’
37. Clinical Impact of Persistent Left Bundle Branch Block After CoreValve Revalving System Implantation. Insight from a Multicenter Italian Registry
38. Response to Letter Regarding Article, “Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System”
39. Interplay Between Mitral Regurgitation and Transcatheter Aortic Valve Replacement With the CoreValve Revalving System
40. Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System
41. Right subclavian approach as a feasible alternative for transcatheter aortic valve implantation with the CoreValve ReValving System
42. TCT-867 Clinical Impact of Persistent Left Bundle Branch Block After CoreValve Revalving System Implantation. Insight from a Multicenter Italian Registry
43. Complementary role of cardiac computed tomography and Doppler-echocardiography in the evaluation of an uncommon case of giant pseudoaneurysm of ascending aorta complicated by fistula to the pulmonary artery
44. Interplay Between Mitral Regurgitation and Transcatheter Aortic Valve Replacement With the Core Valve Revalving System.
45. Abstract 13367: Hemodynamic Determinants of Tricuspid Annular Pulmonary Systolic Excursion (tapse)/ Systolic Pulmonary Arterial Pressure (spap) Ratio in Heart Failure With Reduced Ejection Fraction
46. TCT-751 ONE-YEAR CLINICAL OUTCOMES ACCORDING TO ANTITHROMBOTIC REGIMEN AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION.
47. [Epidemiology of stroke and cerebral protection in patients undergoing transcatheter aortic valve replacement].
48. The new era of oral anticoagulation: the 'finger pointing to the moon is not the moon'. Reply to: Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next? By Job Harenberg, Gregory Y.H. Lip.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.